These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17217621)

  • 1. The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiation.
    Pajonk F; Grumann T; McBride WH
    Neoplasia; 2006 Dec; 8(12):1037-41. PubMed ID: 17217621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
    Birle DC; Hedley DW
    Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism.
    Pajonk F; van Ophoven A; Weissenberger C; McBride WH
    BMC Cancer; 2005 Jul; 5():76. PubMed ID: 16001975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
    Wang J; Sampath A; Raychaudhuri P; Bagchi S
    Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines.
    Zölzer F; Streffer C
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):910-20. PubMed ID: 12377345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
    Kamer S; Ren Q; Dicker AP
    Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
    Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation.
    Koritzinsky M; Wouters BG; Amellem O; Pettersen EO
    Int J Radiat Biol; 2001 Mar; 77(3):319-28. PubMed ID: 11258846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Hypoxia on Out-of-Field Cell Survival after Exposure to Modulated Radiation Fields.
    Thompson HF; Butterworth KT; McMahon SJ; Ghita M; Hounsell AR; Prise KM
    Radiat Res; 2017 Dec; 188(6):636-644. PubMed ID: 29019742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
    Olive PL; Aquino-Parsons C; MacPhail SH; Liao SY; Raleigh JA; Lerman MI; Stanbridge EJ
    Cancer Res; 2001 Dec; 61(24):8924-9. PubMed ID: 11751418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.
    Espinoza I; Peschke P; Karger CP
    Med Phys; 2015 Jan; 42(1):90-102. PubMed ID: 25563250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of quercetin on the activity of purified 20S, 26S proteasome and proteasomal activity in isolated cardiomyocytes].
    Dosenko VE; Nagibin VS; Tumanovskaia LV; Zagoriĭ VIu; Moĭbenko AA
    Biomed Khim; 2006; 52(2):138-45. PubMed ID: 16805384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
    Bennewith KL; Durand RE
    Cancer Res; 2004 Sep; 64(17):6183-9. PubMed ID: 15342403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
    Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
    Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reoxygenation of hypoxic cells by tumor shrinkage during irradiation. A computer simulation.
    Kocher M; Treuer H
    Strahlenther Onkol; 1995 Apr; 171(4):219-30. PubMed ID: 7740410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibition improves fractionated radiation treatment against non-small cell lung cancer: an antioxidant connection.
    Grimes KR; Daosukho C; Zhao Y; Meigooni A; St Clair W
    Int J Oncol; 2005 Oct; 27(4):1047-52. PubMed ID: 16142322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
    Dietz A; Vanselow B; Rudat V; Conradt C; Weidauer H; Kallinowski F; Dollner R
    Head Neck; 2003 Jan; 25(1):50-8. PubMed ID: 12478544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.
    Schilling D; Bayer C; Geurts-Moespot A; Sweep FC; Pruschy M; Mengele K; Sprague LD; Molls M
    BMC Cancer; 2007 Jul; 7():143. PubMed ID: 17663760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
    Ellingsen C; Ovrebø KM; Galappathi K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1317-23. PubMed ID: 22270159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome structures affected by ionizing radiation.
    Pervan M; Iwamoto KS; McBride WH
    Mol Cancer Res; 2005 Jul; 3(7):381-90. PubMed ID: 16046549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.